Volume 24, Number 12—December 2018
Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000–2017
||p value||Severity of illness
|A, n = 17||B, n = 28||C, n = 22||Severe, n = 25||Mild, n = 45|
|Platelets, 109/L||150–360||109 (29–137) ||109 (28–140) ||93 (23–166) ||0.98||23 (9.5–89) ||117 (95–154.3) ||<0.001|
|PTT, %†||70–130||56 (24–71) ||78 (56–86) ||58 (44.5–75) ||0.284||54 (39–66) ||87 (70.5–109.5) ||<0.001|
|FiDD, mg/L||<0.5||47.9 (5.05–83.8) ||9.1 (3.4–85.7) ||14.5 (4.1–80.7) ||0.888||32.9 (5.6–81) ||1.6 (0.6–74.7) ||0.057|
*Values are given as median (interquartile range) [no. missing values] except as indicated. The comparison between patients with mild and severe courses of disease was defined by the level of care they needed. Patients with mild disease were those who were treated in a regular ward or the emergency department, and patients with severe disease were those treated in high surveillance or intensive care units. FiDD, fibrin D-dimers; PTT, partial thromboplastin time.
†PTT was analyzed according to the Owren method (8). PTT was calculated as the ratio of the result (in seconds) from normal plasma to the result (in seconds) from the patient sample x 100.
- Butler T. Capnocytophaga canimorsus: an emerging cause of sepsis, meningitis, and post-splenectomy infection after dog bites. Eur J Clin Microbiol Infect Dis. 2015;34:1271–80.
- Butler T, Weaver RE, Ramani TK, Uyeda CT, Bobo RA, Ryu JS, et al. Unidentified gram-negative rod infection. A new disease of man. Ann Intern Med. 1977;86:1–5.
- Pers C, Gahrn-Hansen B, Frederiksen W. Capnocytophaga canimorsus septicemia in Denmark, 1982-1995: review of 39 cases. Clin Infect Dis. 1996;23:71–5.
- van Dam AP, Jansz A. Capnocytophaga canimorsus infections in The Netherlands: a nationwide survey. Clin Microbiol Infect. 2011;17:312–5.
- Hästbacka J, Hynninen M, Kolho E. Capnocytophaga canimorsus bacteremia: clinical features and outcomes from a Helsinki ICU cohort. Acta Anaesthesiol Scand. 2016;60:1437–43.
- Renzi F, Ittig SJ, Sadovskaya I, Hess E, Lauber F, Dol M, et al. Evidence for a LOS and a capsular polysaccharide in Capnocytophaga canimorsus. Sci Rep. 2016;6:38914.
- Hess E, Renzi F, Koudad D, Dol M, Cornelis GR. Identification of virulent Capnocytophaga canimorsus isolates by capsular typing. J Clin Microbiol. 2017;55:1902–14.
- Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet. 1959;2:754–8.
- Tissari P, Zumla A, Tarkka E, Mero S, Savolainen L, Vaara M, et al. Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study. Lancet. 2010;375:224–30.
- Renzi F, Dol M, Raymackers A, Manfredi P, Cornelis GR. Only a subset of C. canimorsus strains is dangerous for humans. Emerg Microbes Infect. 2016;5:e29.
- Mally M, Shin H, Paroz C, Landmann R, Cornelis GR. Capnocytophaga canimorsus: a human pathogen feeding at the surface of epithelial cells and phagocytes. PLoS Pathog. 2008;4:e1000164.
- Manfredi P, Renzi F, Mally M, Sauteur L, Schmaler M, Moes S, et al. The genome and surface proteome of Capnocytophaga canimorsus reveal a key role of glycan foraging systems in host glycoproteins deglycosylation. Mol Microbiol. 2011;81:1050–60.
- Renzi F, Manfredi P, Mally M, Moes S, Jenö P, Cornelis GR. The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG. PLoS Pathog. 2011;7:e1002118.
- Suzuki M, Kimura M, Imaoka K, Yamada A. Prevalence of Capnocytophaga canimorsus and Capnocytophaga cynodegmi in dogs and cats determined by using a newly established species-specific PCR. Vet Microbiol. 2010;144:172–6.
1These first authors contributed equally to this article.
2These authors were co–principal investigators.